51 - 60 of 9,026 results found for UCL Discovery.
You can read the DCAL Data Archive and Management Policy on UCL Discovery. ... For more information, and to discuss access to the restricted data, contact firstname.lastname@example.org.
Immune cell health discovery could optimise cancer therapies | UCL News - UCL – University College Londonhttps://www.ucl.ac.uk/news/2020/jan/immune-cell-health-discovery-could-optimise-cancer-therapies
The study was led by UCL Division of Infection &Immunity, with support from UCL Institute for Liver &Digestive Health, King’ s College London, QMUL and the University of Oxford. ... Media contact . Henry Killworth. Tel: 44 (0) 207 679 5296. E:
Departments in the UCL School of Pharmacy | UCL School of Pharmacy - UCL – University College Londonhttps://www.ucl.ac.uk/pharmacy/about/departments-ucl-school-pharmacy
PhD studentships are available through UCL and Pharmacy training programmes or by contacting staff directly. ... The programme teaches advanced experimental approaches in pharmacology coupled with current developments in drug discovery and therapeutics.
approach. Mr Richard Gunu. Research Associate/Biomedical Scientist. Email: email@example.com. ... Ms Jiran Vatankhah Atashgah. Clinical Research Nurse. Email: firstname.lastname@example.org.
Gene discovery helps children with movement disorder walk again | UCL News - UCL – University College Londonhttps://www.ucl.ac.uk/news/headlines/2016/dec/gene-discovery-helps-children-movement-disorder-walk-again
Gene discovery helps children with movement disorder walk again. 20 December 2016. ... A team led by Dr Manju Kurian (UCL Great Ormond Street Institute of Child Health) has discovered a new genetic cause for a movement disorder, allowing a treatment
management advisory services for the national caseload of patients with amyloidosis and hereditary periodic fever syndromes, and the Wolfson Drug Discovery Unit. ... Director of the Wolfson Drug Discovery Unit.
Professor Ioannis Lianos, UCL. Professor Caio Mario da Silva Pereira Neto, FGV Law School. ... Convened by. Professor Ioannis Lianos,. Director, Centre for Law, Economics and Society, UCL.
Bioactive Coatings. The science behind the research. Due to its excellent biocompatible properties hydroxyapatite can be integrated into dental implants, bioactive surface for bone growth of human body, and biomedical implants. Ongoing research. In
New genetics discovery paves the way to transform immunotherapy treatments | UCL Cancer Institute - UCL – University College Londonhttps://www.ucl.ac.uk/cancer/news/new-landmark-genetics-discovery-paves-the-way-to-transform-immunotherapy-treaments
New genetics discovery paves the way to transform immunotherapy treatments. 11 March 2016. ... Rosetrees Trust and involved researchers from UCL, Harvard and Massachusetts Institute of Technology.
People. The UCL Institute for Materials Discovery (IMD) was created to put UCL at the forefront of the design and development of sustainable, novel, high-performance materials.